Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.
about
Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosisErk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4)Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cellsLymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axisNeuropilins: expression and roles in the epitheliumA perspective on the role of class III semaphorin signaling in central nervous system traumaAnti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.Normalization of the vasculature for treatment of cancer and other diseases.ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells.Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cellsMechanochemical control of mesenchymal condensation and embryonic tooth organ formation.Tumour vascularization: sprouting angiogenesis and beyondHormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motilityId2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3FHypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.Krüpple-like factors in the central nervous system: novel mediators in stroke.Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in miceA mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progressionRORα suppresses breast tumor invasion by inducing SEMA3F expressionAssay development for the discovery of semaphorin 3B inducing agents from natural product sources.A role for neuropilins in the interaction between Schwann cells and meningeal cells.Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction.Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates.Tumor-penetrating iRGD peptide inhibits metastasis.The semaphorins."Go with the flow": how Krüppel-like factor 2 regulates the vasoprotective effects of shear stress.Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2.Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal CancersPlexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cellsNeuropilin-2: a novel biomarker for malignant melanoma?Semaphorins in angiogenesis and tumor progression.Regulation of mTOR Signaling by Semaphorin 3F-Neuropilin 2 Interactions In Vitro and In Vivo.Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanismSemaphorin signaling in angiogenesis, lymphangiogenesis and cancerGenetic Identification of SEMA3F as an Antilymphangiogenic Metastasis Suppressor Gene in Head and Neck Squamous CarcinomaClass 3 semaphorins negatively regulate dermal lymphatic network formation.
P2860
Q24298191-A8BECE91-2BA2-414A-811B-D96F13A8E0F7Q24309731-577985AD-D628-433D-A10C-C608341F2472Q24321689-2F5FA8F7-28B4-4154-BCC7-A7B596BE81E3Q24550871-649F4BF5-4B8B-4BED-BD06-FBEE5740003CQ26825144-14A4B36B-1111-4157-9A56-92BF23160726Q26998786-21A123E8-6944-445A-9B72-3A34356B6488Q28251368-0BFDEBA2-7CE3-4565-8DD8-25EB25EC3F2FQ30388655-DB84BF94-ABFE-40E1-8899-FD0848366D7FQ30471456-F7A01721-5597-4E7E-8924-BC104BD808BBQ30483797-4267801D-CB94-404C-A875-2AB7B72CAAC0Q33372124-424432DD-4B45-4174-9758-E8B5ACAD2EDCQ33390446-69FF29CE-7972-4336-A39D-AA37EA5B0929Q33556162-6CA72700-4A28-4AB6-8ABE-CD5FBA5F69F5Q33647661-377A9B7B-8C2E-492B-A815-01BABCD6C563Q33797591-88067565-80A6-46AB-926A-20CFDEA2F818Q33820517-FFDEB2F2-DCA5-4D97-B194-13279202E3C6Q33826605-2CE9CEB8-14DB-4F5F-8859-7FF697D36F96Q33899627-DB7BF11F-AF2E-4D6F-8C6B-4D22FC26A79DQ33962267-A32BA358-619C-4826-BE49-FBA5454EE661Q34028716-A4248FBD-3998-48A8-BBB7-0668B8622A9EQ34073272-2A2EB854-329B-4B6F-8EAA-55D593079249Q34255775-B3B306DC-AEF8-4362-A73A-7498DC6052C8Q34337052-999998FC-C8D3-4260-A8A2-4D7B472299E1Q34338200-8C3B9319-43F7-4D6E-9053-7DF6450B17B3Q34694762-93F85CB4-049E-4EF1-BAE8-86E644AA3B59Q34762113-5F9252C4-A346-4765-9046-AC177E220EA8Q34972161-634B912C-8D61-435D-A6BB-4E41FB9EA29DQ34978216-C4EE0935-CA4F-47B3-A327-128A3836EDCDQ35012897-AB8C442A-A5EE-40C8-B789-DD1B0990D757Q35130262-6E938FF0-AD5E-4F88-A114-6E882A9302A4Q35533847-6F1F81DB-BD38-4FEF-B059-1E4230617508Q35593032-0B7682AB-232E-42AD-B4BA-596F788BC62AQ35615400-C8679FD1-9058-4640-BB55-F787D1C5C449Q35634243-5BEAEE6B-D749-45B2-AE34-967525DA55AEQ35658200-62DD0E77-BCB5-44CB-9D80-CC59B72F6671Q35834072-B542F973-BFB5-461C-83B5-65DEE05828C2Q35836025-C76A5847-B2ED-40F1-8B6D-EA4C8684443AQ35958869-AC71B68D-4DBB-4153-A320-376E60155D32Q35962330-13F07E0E-5050-4CA1-A1DF-E1087C71D7D7Q36090884-97FC685A-9BD6-4164-8E7B-FB325FA6BAB7
P2860
Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Semaphorin 3F, a chemorepulsan ...... nonmetastatic tumor phenotype
@nl
Semaphorin 3F, a chemorepulsan ...... nonmetastatic tumor phenotype.
@ast
Semaphorin 3F, a chemorepulsan ...... nonmetastatic tumor phenotype.
@en
type
label
Semaphorin 3F, a chemorepulsan ...... nonmetastatic tumor phenotype
@nl
Semaphorin 3F, a chemorepulsan ...... nonmetastatic tumor phenotype.
@ast
Semaphorin 3F, a chemorepulsan ...... nonmetastatic tumor phenotype.
@en
prefLabel
Semaphorin 3F, a chemorepulsan ...... nonmetastatic tumor phenotype
@nl
Semaphorin 3F, a chemorepulsan ...... nonmetastatic tumor phenotype.
@ast
Semaphorin 3F, a chemorepulsan ...... nonmetastatic tumor phenotype.
@en
P2093
P2860
P356
P1476
Semaphorin 3F, a chemorepulsan ...... nonmetastatic tumor phenotype.
@en
P2093
Akio Shimizu
Arja Kaipainen
Caroline Choi Kim
Diane R Bielenberg
Michael Klagsbrun
Michael Kreuter
Yasuhiro Hida
P2860
P304
P356
10.1172/JCI21378
P407
P577
2004-11-01T00:00:00Z